Patents by Inventor Philippe Collery

Philippe Collery has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Rhenium complexes and their pharmaceutical use
    Patent number: 8987491
    Abstract: The present invention is directed to a rhenium complex of general Formula (I) or a pharmaceutically acceptable salt or solvate thereof, wherein X is Se; Y is NH, O or S or is a methylene group; Z is halogen; m=0, 1, or 2 and p=0, 1, or 2, provided that m and p are both different from zero when Y is NH, O or S; n=3; R? is a phenyl group or a group of general Formula —(CH2)q—COOH wherein q=1 or 2, a pharmaceutical composition comprising a therapeutically effective amount of at least one of such rhenium complex where X is additionally S or Te, a method for preparing said rhenium complex and a method for treating a proliferative growth related-disorder using a therapeutically effective amount of at least one of said rhenium complex where X is additionally S or Te. Also claimed is the use of compounds of formula (II) in the preparation of compounds of formula (I).
    Type: Grant
    Filed: June 1, 2011
    Date of Patent: March 24, 2015
    Assignees: Societe de Coordination de Recherches Therapeutiques, Universite Paris-Sud 11, Centre National de la Recherche Scientifique
    Inventors: Philippe Collery, Jean D'Angelo, Georges Morgant
  • RHENIUM COMPLEXES AND THEIR PHARMACEUTICAL USE
    Publication number: 20130158109
    Abstract: The present invention is directed to a rhenium complex of general Formula (I) or a pharmaceutically acceptable salt or solvate thereof, wherein X is Se; Y is NH, O or S or is a methylene group; Z is halogen; m=0, 1, or 2 and p=0, 1, or 2, provided that m and p are both different from zero when Y is NH, O or S; n=3; R? is a phenyl group or a group of general Formula —(CH2)q—COOH wherein q=1 or 2, a pharmaceutical composition comprising a therapeutically effective amount of at least one of such rhenium complex where X is additionally S or Te, a method for preparing said rhenium complex and a method for treating a proliferative growth related-disorder using a therapeutically effective amount of at least one of said rhenium complex where X is additionally S or Te. Also claimed is the use of compounds of formula (II) in the preparation of compounds of formula (I).
    Type: Application
    Filed: June 1, 2011
    Publication date: June 20, 2013
    Applicants: CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE, UNIVERSITE PARIS-SUD 11
    Inventors: Philippe Collery, Jean D'Angelo, Georges Morgant
  • Gallium (III) complexes in pharmaceutical compositions
    Patent number: 5525598
    Abstract: A method for treatment of viral infections or tumors, comprising administering a gallium complex of the formula: ##STR1## wherein R.sub.1 represents hydrogen, a halogen or a sulfono group SO.sub.3 M in which M is a metal ion such as potassium or sodium, and R.sub.2 represents hydrogen, or R.sub.1 is chlorine and R.sub.2 is iodo.
    Type: Grant
    Filed: January 24, 1994
    Date of Patent: June 11, 1996
    Assignees: Phillippe Collery, Bernhard Keppler
    Inventors: Philippe Collery, Bernhard Keppler
  • Gallium chloride as a new anti-cancerous drug
    Patent number: 4596710
    Abstract: The present invention relates to the application of gallium chloride as drug particularly useful for the treatment of malignant tumors, and to the pharmaceutical compositions particularly intended for oral administration and containing from 100 to 500 mg of active ingredient per unit dose.
    Type: Grant
    Filed: May 11, 1984
    Date of Patent: June 24, 1986
    Assignee: Les Laboratoires Meram
    Inventor: Philippe Collery